Therapist guided internet based cognitive behavioural therapy for body dysmorphic disorder: single blind randomised controlled trial

Jesper Enander, Erik Andersson, David Mataix-Cols, Linn Lichtenstein, Katarina Alström, Gerhard Andersson, Brjánn Ljótsson, Christian Rück, Jesper Enander, Erik Andersson, David Mataix-Cols, Linn Lichtenstein, Katarina Alström, Gerhard Andersson, Brjánn Ljótsson, Christian Rück

Abstract

Objectives: To evaluate the efficacy of therapist guided internet based cognitive behavioural therapy (CBT) programme for body dysmorphic disorder (BDD-NET) compared with online supportive therapy.

Design: A 12 week single blind parallel group randomised controlled trial.

Setting: Academic medical centre.

Participants: 94 self referred adult outpatients with a diagnosis of body dysmorphic disorder and a modified Yale-Brown obsessive compulsive scale (BDD-YBOCS) score of ≥ 20. Concurrent psychotropic drug treatment was permitted if the dose had been stable for at least two months before enrolment and remained unchanged during the trial.

Interventions: Participants received either BDD-NET (n=47) or supportive therapy (n=47) delivered via the internet for 12 weeks.

Main outcome measures: The primary outcome was the BDD-YBOCS score after treatment and follow-up (three and six months from baseline) as evaluated by a masked assessor. Responder status was defined as a ≥ 30% reduction in symptoms on the scale. Secondary outcomes were measures of depression (MADRS-S), global functioning (GAF), clinical global improvement (CGI-I), and quality of life (EQ5D). The six month follow-up time and all outcomes other than BDD-YBOCS and MADRS-S at 3 months were not pre-specified in the registration at clinicaltrials.gov because of an administrative error but were included in the original trial protocol approved by the regional ethics committee before the start of the trial.

Results: BDD-NET was superior to supportive therapy and was associated with significant improvements in severity of symptoms of body dysmorphic disorder (BDD-YBOCS group difference -7.1 points, 95% confidence interval -9.8 to -4.4), depression (MADRS-S group difference -4.5 points, -7.5 to -1.4), and other secondary measures. At follow-up, 56% of those receiving BDD-NET were classed as responders, compared with 13% receiving supportive therapy. The number needed to treat was 2.34 (1.71 to 4.35). Self reported satisfaction was high.

Conclusions: CBT can be delivered safely via the internet to patients with body dysmorphic disorder. BDD-NET has the potential to increase access to evidence based psychiatric care for this mental disorder, in line with NICE priority recommendations. It could be particularly useful in a stepped care approach, in which general practitioner or other mental health professionals can offer treatment to people with mild to moderate symptoms at low risk of suicide.Trial registration ClinicalTrials.gov ID: NCT02010619.

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Figures

https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4785812/bin/enaj027352.f1_default.jpg
Fig 1 Flow of participants with body dysmorphic disorder (BDD) through study of therapist guided internet based cognitive behavioural therapy (BDD-NET)
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4785812/bin/enaj027352.f2_default.jpg
Fig 2 Effect of treatment over time on Yale-Brown obsessive compulsive scale modified for body dysmorphic disorder (BDD-YBOCS) with 95% confidence intervals. Scores are shown at baseline, after treatment (3 months), and follow-up (6 months) according to treatment group. Six month follow-up point was not registered at clinicaltrials.gov because of administrative error
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4785812/bin/enaj027352.f3_default.jpg
Fig 3 Mean scores of participants initially randomised to supportive therapy who crossed over to BDD-NET (n=41) and received 12 weeks of additional treatment after 6 month follow-up

References

    1. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders. 5th ed American Psychiatric Publishing, 2013.
    1. Phillips KA, Menard W, Quinn E, Didie ER, Stout RL. A 4-year prospective observational follow-up study of course and predictors of course in body dysmorphic disorder. Psychol Med 2013;43:1109-17. 10.1017/S0033291712001730. .
    1. Phillips KA, Menard W, Fay C, Pagano ME. Psychosocial functioning and quality of life in body dysmorphic disorder. Compr Psychiatry 2005;46:254-60. 10.1016/j.comppsych.2004.10.004. .
    1. Phillips KA, Menard W. Suicidality in body dysmorphic disorder: a prospective study. Am J Psychiatry 2006;163:1280-2. 10.1176/ajp.2006.163.7.1280. .
    1. Grant JE, Kim SW, Crow SJ. Prevalence and clinical features of body dysmorphic disorder in adolescent and adult psychiatric inpatients. J Clin Psychiatry 2001;62:517-22. 10.4088/JCP.v62n07a03. .
    1. Kollei I, Martin A, Rein K, Rotter A, Jacobi A, Mueller A. Prevalence of body dysmorphic disorder in a German psychiatric inpatient sample. Psychiatry Res 2011;189:153-5. 10.1016/j.psychres.2011.02.009. .
    1. Brohede S, Wingren G, Wijma B, Wijma K. Prevalence of body dysmorphic disorder among Swedish women: a population-based study. Compr Psychiatry 2015;58:108-15. 10.1016/j.comppsych.2014.12.014. .
    1. Otto MW, Wilhelm S, Cohen LS, Harlow BL. Prevalence of body dysmorphic disorder in a community sample of women. Am J Psychiatry 2001;158:2061-3. 10.1176/appi.ajp.158.12.2061. .
    1. Rief W, Buhlmann U, Wilhelm S, Borkenhagen A, Brähler E. The prevalence of body dysmorphic disorder: a population-based survey. Psychol Med 2006;36:877-85. 10.1017/S0033291706007264. .
    1. Buhlmann U, Glaesmer H, Mewes R, et al. Updates on the prevalence of body dysmorphic disorder: a population-based survey. Psychiatry Res 2010;178:171-5. 10.1016/j.psychres.2009.05.002. .
    1. Crerand CE, Phillips KA, Menard W, Fay C. Nonpsychiatric medical treatment of body dysmorphic disorder. Psychosomatics 2005;46:549-55. 10.1176/appi.psy.46.6.549. .
    1. Sarwer DB, Spitzer JC. Body image dysmorphic disorder in persons who undergo aesthetic medical treatments. Aesthet Surg J 2012;32:999-1009. 10.1177/1090820X12462715. .
    1. Ipser JC, Sander C, Stein DJ. Pharmacotherapy and psychotherapy for body dysmorphic disorder. Cochrane Database Syst Rev 2009;1CD005332. 10.1002/14651858.CD005332.pub2. ..
    1. Wilhelm S, Phillips KA, Didie E, et al. Modular cognitive-behavioral therapy for body dysmorphic disorder: a randomized controlled trial. Behav Ther 2014;45:314-27. 10.1016/j.beth.2013.12.007. .
    1. Veale D, Anson M, Miles S, Pieta M, Costa A, Ellison N. Efficacy of cognitive behaviour therapy versus anxiety management for body dysmorphic disorder: a randomised controlled trial. Psychother Psychosom 2014;83:341-53. 10.1159/000360740. ..
    1. Mataix-Cols D, Fernández de la Cruz L, Isomura K, et al. A pilot randomized controlled trial of cognitive-behavioral therapy for adolescents with body dysmorphic disorder. J Am Acad Child Adolesc Psychiatry 2015;54:895-904.. 10.1016/j.jaac.2015.08.011. .
    1. National Institute for Health and Care Excellence. Obsessive-compulsive Disorder: Core Interventions in the Treatment of Obsessive-compulsive Disorder and Body Dysmorphic Disorder. CG31.National Institute for Health and Care Excellence, 2005.
    1. Cavanagh K. Geographic inequity in the availability of cognitive behavioural therapy in England and Wales: a 10-year update. Behav Cogn Psychother 2014;42:497-501.. 10.1017/S1352465813000568. .
    1. Marques L, Weingarden HM, Leblanc NJ, Wilhelm S. Treatment utilization and barriers to treatment engagement among people with body dysmorphic symptoms. J Psychosom Res 2011;70:286-93.. 10.1016/j.jpsychores.2010.10.002. .
    1. Buhlmann U. Treatment barriers for individuals with body dysmorphic disorder: an internet survey. J Nerv Ment Dis 2011;199:268-71. 10.1097/NMD.0b013e31821245ce. .
    1. Hollis C, Morriss R, Martin J, et al. Technological innovations in mental healthcare: harnessing the digital revolution. Br J Psychiatry 2015;206:263-5. 10.1192/bjp.bp.113.142612. .
    1. Department of Health. No Health Without Mental Health.Department of Health, 2011.
    1. Hedman E. Therapist guided internet delivered cognitive behavioural therapy. BMJ 2014;348:g1977. 10.1136/bmj.g1977. .
    1. Andersson G, Cuijpers P, Carlbring P, Riper H, Hedman E. Guided Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: a systematic review and meta-analysis. World Psychiatry 2014;13:288-95. 10.1002/wps.20151. .
    1. Enander J, Ivanov VZ, Andersson E, Mataix-Cols D, Ljótsson B, Rück C. Therapist-guided. Therapist-guided, Internet-based cognitive-behavioural therapy for body dysmorphic disorder (BDD-NET): a feasibility study. BMJ Open 2014;4:e005923. 10.1136/bmjopen-2014-005923. .
    1. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008;148:295-309. 10.7326/0003-4819-148-4-200802190-00008. .
    1. Phillips KA, Hollander E, Rasmussen SA, Aronowitz BR, DeCaria C, Goodman WK. A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. Psychopharmacol Bull 1997;33:17-22..
    1. Svanborg P, Asberg M. A new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating Scale. Acta Psychiatr Scand 1994;89:21-8. 10.1111/j.1600-0447.1994.tb01480.x. .
    1. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption. Addiction 1993;88:791-804. 10.1111/j.1360-0443.1993.tb02093.x. .
    1. Berman AH, Bergman H, Palmstierna T, Schlyter F. Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res 2005;11:22-31. 10.1159/000081413. .
    1. Brohede S, Wingren G, Wijma B, Wijma K. Validation of the Body Dysmorphic Disorder Questionnaire in a community sample of Swedish women. Psychiatry Res 2013;210:647-52. 10.1016/j.psychres.2013.07.019. .
    1. Rohde P, Lewinsohn PM, Seeley JR. Comparability of telephone and face-to-face interviews in assessing axis I and II disorders. Am J Psychiatry 1997;154:1593-8. 10.1176/ajp.154.11.1593. .
    1. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl 20):22-33, quiz 34-57..
    1. Andersson E, Enander J, Andrén P, et al. Internet-based cognitive behaviour therapy for obsessive-compulsive disorder: a randomized controlled trial. Psychol Med 2012;42:2193-203. 10.1017/S0033291712000244. .
    1. Coles ME, Cook LM, Blake TR. Assessing obsessive compulsive symptoms and cognitions on the internet: evidence for the comparability of paper and Internet administration. Behav Res Ther 2007;45:2232-40. 10.1016/j.brat.2006.12.009. .
    1. Enander J, Andersson E, Kaldo V, et al. Internet administration of the Dimensional Obsessive-Compulsive Scale: a psychometric evaluation. J Obsessive Compuls Relat Disord 2012;1:325-30. 10.1016/j.jocrd.2012.07.008. .
    1. Phillips KA, Hart AS, Menard K. Psychometric evaluation of the Yale-Brown Obsessive-Compulsive Scale Modified for Body Dysmorphic Disorder (BDD-YBOCS). J Obsessive Compul Relat Disord 2014;3:205-8. 10.1016/j.jocrd.2014.04.004. .
    1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 4th ed American Psychiatric Association, 2000.
    1. Guy W, ed. Clinical global impressions .US Department of Health and Human Services, 1976.
    1. EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208. 10.1016/0168-8510(90)90421-9. .
    1. Ljótsson B, Hesser H, Andersson E, et al. Provoking symptoms to relieve symptoms: a randomized controlled dismantling study of exposure therapy in irritable bowel syndrome. Behav Res Ther 2014;55:27-39. 10.1016/j.brat.2014.01.007. .
    1. Devilly GJ, Borkovec TD. Psychometric properties of the credibility/expectancy questionnaire. J Behav Ther Exp Psychiatry 2000;31:73-86. 10.1016/S0005-7916(00)00012-4. .
    1. Verbeke G, Molenberghs G. Linear Mixed Models for Longitudinal Data.Springer Science & Business Media, 2000.

Source: PubMed

3
S'abonner